• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 677

Docosahexaenoic acid oil produced in Schizochytrium sp.

Intended Use: Intended for use as an ingredient in exempt (pre-term) and non-exempt (term) infant formula (ages from birth to 12 months) in accordance with current good manufacturing practices and in combination with a source of arachidonic acid.
Basis: Scientific procedures
Notifier: Mara Renewables Corporation
Notifier Address: 101 Research Drive; Dartmouth NS B2Y 4 T6, Canada
GRAS Notice (releasable information): GRN 677 (in PDF) (12.0 MB)
Date of closure: May 2, 2017
FDA's Letter: FDA has no questions (in PDF) (101 kB)